Literature DB >> 21830629

Men's perspectives on selecting their prostate cancer treatment.

Jinping Xu1, Rhonda K Dailey, Susan Eggly, Anne Victoria Neale, Kendra L Schwartz.   

Abstract

OBJECTIVE: In the context of scientific uncertainty, treatment choices for localized prostate cancer vary, but reasons for this variation are unclear. We explored how black and white American men made their treatment decision.
METHODS: Guided by conceptual model, we conducted semistructured interviews of 21 American (14 black and 7 white) men with recently diagnosed localized prostate cancer.
RESULTS: Physician recommendation was very important in the treatment decision, but patient self-perception/values and attitudes/beliefs about prostate cancer were also influential. Patients who chose surgery believed it offered the best chance of cure and were more concerned that the cancer might spread if not surgically removed. Patients who chose radiation therapy believed it offered equal efficacy of cure but fewer side effects than surgery. Fear of future consequences was the most common reason to reject watchful waiting. Anecdotal experiences of family and friends were also important, especially in deciding "what not to do." The new technology of robotic-assisted prostatectomy provided optimism for men who wanted surgery but feared morbidity associated with traditional open surgery. Few men seemed aware that treatment did not guarantee improved survival.
CONCLUSION: Most men reported making "the best choice for me" by taking into account medical information and personal factors. Perceptions of treatment efficacy and side effects, which derived mainly from physicians' descriptions and/or anecdotal experiences of family and friends, were the most influential factors in men's treatment decision. By understanding factors that influence patients' treatment decisions, clinicians may be more sensitive to individual patients' preferences/concerns and provide more patient-centered care.

Entities:  

Mesh:

Year:  2011        PMID: 21830629      PMCID: PMC4283563          DOI: 10.1016/s0027-9684(15)30359-x

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  19 in total

1.  Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.

Authors:  Willie Underwood; James Jackson; John T Wei; Rodney Dunn; Edmond Baker; Sonya Demonner; David P Wood
Journal:  Cancer       Date:  2005-02-01       Impact factor: 6.860

Review 2.  Outcomes after robot-assisted laparoscopic radical prostatectomy.

Authors:  Declan G Murphy; Benjamin J Challacombe; Anthony J Costello
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

3.  Trust in the health care system and the use of preventive health services by older black and white adults.

Authors:  Donald Musa; Richard Schulz; Roderick Harris; Myrna Silverman; Stephen B Thomas
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

4.  Racial disparity in primary and adjuvant treatment for nonmetastatic prostate cancer: SEER-Medicare trends 1991 to 1999.

Authors:  Steven B Zeliadt; Arnold L Potosky; Ruth Etzioni; Scott D Ramsey; David F Penson
Journal:  Urology       Date:  2004-12       Impact factor: 2.649

5.  Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.

Authors:  Thomas D Denberg; Trisha V Melhado; John F Steiner
Journal:  Cancer       Date:  2006-08-01       Impact factor: 6.860

6.  Making decisions about treatment for localized prostate cancer.

Authors:  S K Steginga; S Occhipinti; R A Gardiner; J Yaxley; P Heathcote
Journal:  BJU Int       Date:  2002-02       Impact factor: 5.588

7.  Interplay of race, socioeconomic status, and treatment on survival of patients with prostate cancer.

Authors:  Kendra Schwartz; Isaac J Powell; Willie Underwood; Julie George; Cecilia Yee; Mousumi Banerjee
Journal:  Urology       Date:  2009-12       Impact factor: 2.649

8.  Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy.

Authors:  Florian R Schroeck; Tracey L Krupski; Leon Sun; David M Albala; Marva M Price; Thomas J Polascik; Cary N Robertson; Alok K Tewari; Judd W Moul
Journal:  Eur Urol       Date:  2008-06-23       Impact factor: 20.096

9.  Comparative effectiveness of minimally invasive vs open radical prostatectomy.

Authors:  Jim C Hu; Xiangmei Gu; Stuart R Lipsitz; Michael J Barry; Anthony V D'Amico; Aaron C Weinberg; Nancy L Keating
Journal:  JAMA       Date:  2009-10-14       Impact factor: 56.272

10.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Authors:  H Gilbert Welch; Peter C Albertsen
Journal:  J Natl Cancer Inst       Date:  2009-08-31       Impact factor: 13.506

View more
  32 in total

1.  Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates.

Authors:  Amy J Starosta; George Luta; Catherine A Tomko; Marc D Schwartz; Kathryn L Taylor
Journal:  Ann Behav Med       Date:  2015-10

2.  Are HIV-infected men vulnerable to prostate cancer treatment disparities?

Authors:  Adam B Murphy; Ramona Bhatia; Iman K Martin; David A Klein; Courtney M P Hollowell; Yaw Nyame; Elodi Dielubanza; Chad Achenbach; Rick A Kittles
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-07-25       Impact factor: 4.254

3.  Treatment decision making in early-stage papillary thyroid cancer.

Authors:  Thomas A D'Agostino; Elyse Shuk; Erin K Maloney; Rebecca Zeuren; R Michael Tuttle; Carma L Bylund
Journal:  Psychooncology       Date:  2017-02-27       Impact factor: 3.894

4.  Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Authors:  J S Blumenthal-Barby; Denise Lee; Robert J Volk
Journal:  CA Cancer J Clin       Date:  2015-05-21       Impact factor: 508.702

5.  Active surveillance for prostate cancer: an underutilized opportunity for reducing harm.

Authors:  H Ballentine Carter
Journal:  J Natl Cancer Inst Monogr       Date:  2012-12

6.  Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.

Authors:  Jinping Xu; James Janisse; Julie Ruterbusch; Joel Ager; Kendra L Schwartz
Journal:  J Racial Ethn Health Disparities       Date:  2015-05-05

7.  Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

Authors:  Netty Kinsella; Pär Stattin; Declan Cahill; Christian Brown; Anna Bill-Axelson; Ola Bratt; Sigrid Carlsson; Mieke Van Hemelrijck
Journal:  Eur Urol       Date:  2018-03-26       Impact factor: 20.096

8.  Active surveillance for low-risk localized prostate cancer: what do men and their partners think?

Authors:  Arun Mallapareddi; Julie Ruterbusch; Elyse Reamer; Susan Eggly; Jinping Xu
Journal:  Fam Pract       Date:  2016-12-29       Impact factor: 2.267

9.  Cognitive and Affective Representations of Active Surveillance as a Treatment Option for Low-Risk Prostate Cancer.

Authors:  Kathleen D Lyons; Hsin H Li; Emily M Mader; Telisa M Stewart; Christopher P Morley; Margaret K Formica; Scott D Perrapato; John D Seigne; Elias S Hyams; Brian H Irwin; Terry Mosher; Mark T Hegel
Journal:  Am J Mens Health       Date:  2016-07-07

10.  Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.

Authors:  Jinping Xu; James Janisse; Julie J Ruterbusch; Joel Ager; Joe Liu; Margaret Holmes-Rovner; Kendra L Schwartz
Journal:  Ann Fam Med       Date:  2016-05       Impact factor: 5.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.